Long-term effect of strontium ranelate treatment on BMD.
Blake
Glen M
GM
Fogelman
Ignac
I
D000465:Algorithms; D000818:Animals; D015519:Bone Density / Q000187:drug effects*; D050071:Bone Density Conservation Agents / Q000494:pharmacology; D001842:Bone and Bones / Q000378:metabolism; D002986:Clinical Trials as Topic; D050723:Fractures, Bone / Q000517:prevention & control; D006801:Humans; D008252:Macaca fascicularis; D009942:Organometallic Compounds / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D010024:Osteoporosis / Q000188:drug therapy; D013324:Strontium / Q000378:metabolism; D013876:Thiophenes / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use
D050071:Bone Density Conservation Agents; D009942:Organometallic Compounds; D013876:Thiophenes; C081587:strontium ranelate; D013324:Strontium